Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jan;6(1):32-5.
doi: 10.1177/1941874415580597.

Morvan Syndrome: A Case Report With Patient Narrative and Video

Affiliations

Morvan Syndrome: A Case Report With Patient Narrative and Video

Mark Maskery et al. Neurohospitalist. 2016 Jan.

Abstract

A 74-year-old gentleman was admitted to the regional neurosciences center with encephalopathy, myokymia, and dysautonomia. Chest imaging had previously identified an incidental mass in the anterior mediastinum, consistent with a primary thymic tumor. Antivoltage-gated potassium channel (anti-VGKC) antibodies were positive (titer 1273 pmol/L) and he was hypokalemic. Electromyogram and nerve conduction studies were in keeping with peripheral nerve hyperexcitability syndrome, and an electroencephalogram was consistent with encephalopathy. A diagnosis of Morvan syndrome was made, for which he was initially treated with high-dose steroids, followed by a 5-day course of intravenous immunoglobulin (IVIG) therapy. He also underwent thymectomy, followed by a postexcision flare of his symptoms requiring intensive care management. Further steroids, plasmapheresis, and IVIG achieved stabilization of his clinical condition, enabling transfer for inpatient neurorehabilitation. He was commenced on azathioprine and a prolonged oral steroid taper. A subsequent presumed incipient relapse responded well to further IVIG treatment. This case report documents a thymoma-associated presentation of anti-VGKC-positive Morvan syndrome supplemented by patient and carer narrative and video, both of which provide valuable further insights into this rare disorder. There are a limited number of publications surrounding this rare condition available in the English literature. This, combined with the heterogenous presentation, association with underlying malignancy, response to treatment, and prognosis, provides a diagnostic challenge. However, the association with anti-VGKC antibody-associated complexes and 2 recent case series have provided some scope for both accurate diagnosis and management.

Keywords: electromyogram/nerve conduction studies; general neurology; neurooncology.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting Interests: The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

References

    1. Maddison P. Neuromyotonia. Clin Neurophysiol. 2006;117(10):2118–2127. - PubMed
    1. Loscher WN, Wanschitz J, Reiners K, Quasthoff S. Morvan’s syndrome: clinical, laboratory, and in vitro electrophysiological studies. Muscle Nerve. 2004;30(2):157–163. - PubMed
    1. Cottrell DA, Blackmore KJ, Fawcett PRW, et al. Sub-acute presentation of Morvan’s syndrome after thymectomy. J Neurol Neurosurg Psychiatry. 2004;75(10):1504–1505. - PMC - PubMed
    1. Irani SR, Waters P, Beeson D, Lang B, Vincent A. A novel antigenic target in Morvan’s syndrome. J Neuroimmunol. 2008;203(2):181–181.
    1. Irani SR, Pettingill P, Kleopa KA, et al. Morvan syndrome: clinical and serological observations in 29 cases. Ann Neurol. 2012;72(2):241–255. - PubMed

LinkOut - more resources